Search Results - Hui, Rina
- Showing 1 - 4 results of 4
-
1
Pembrolizumab plus pemetrexed and platinum in nonsquamous non-small-cell lung cancer: 5-year outcomes from the phase 3 KEYNOTE-189 study by Garassino, Marina (Author) , Gadgeel, Shirish (Author) , Speranza, Giovanna (Author) , Felip, Enriqueta (Author) , Esteban, Emilio (Author) , Dómine, Manuel (Author) , Hochmair, Maximilian (Author) , Powell, Steven F. (Author) , Bischoff, Helge (Author) , Peled, Nir (Author) , Grossi, Francesco (Author) , Jennens, Ross R. (Author) , Reck, Martin (Author) , Hui, Rina (Author) , Garon, Edward B. (Author) , Kurata, Takayasu (Author) , Gray, Jhanelle E. (Author) , Schwarzenberger, Paul (Author) , Jensen, Erin (Author) , Pietanza, M. Catherine (Author) , Rodríguez-Abreu, Delvys (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies by Schöffski, Patrick (Author) , Tan, Daniel S.-W. (Author) , Martín, Miguel (Author) , Ochoa-de-Olza, María (Author) , Sarantopoulos, John (Author) , Carvajal, Richard D. (Author) , Kyi, Chrisann (Author) , Esaki, Taito (Author) , Prawira, Amy (Author) , Akerley, Wallace (Author) , Braud, Filippo De (Author) , Hui, Rina (Author) , Zhang, Tian (Author) , Soo, Ross A. (Author) , Maur, Michela (Author) , Weickhardt, Andrew (Author) , Krauß, Jürgen (Author) , Deschler-Baier, Barbara (Author) , Lau, Allen (Author) , Samant, Tanay S. (Author) , Longmire, Tyler (Author) , Chowdhury, Niladri Roy (Author) , Sabatos-Peyton, Catherine A. (Author) , Patel, Nidhi (Author) , Ramesh, Radha (Author) , Hu, Tiancen (Author) , Carion, Ana (Author) , Gusenleitner, Daniel (Author) , Yerramilli-Rao, Padmaja (Author) , Askoxylakis, Vasileios (Author) , Kwak, Eunice L. (Author) , Hong, David S. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
3
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer... by Garassino, Marina (Author) , Gadgeel, Shirish (Author) , Esteban, Emilio (Author) , Felip, Enriqueta (Author) , Speranza, Giovanna (Author) , Domine, Manuel (Author) , Hochmair, Maximilian J. (Author) , Powell, Steven (Author) , Cheng, Susanna Yee-Shan (Author) , Bischoff, Helge (Author) , Peled, Nir (Author) , Reck, Martin (Author) , Hui, Rina (Author) , Garon, Edward B. (Author) , Boyer, Michael (Author) , Wei, Ziwen (Author) , Burke, Thomas (Author) , Pietanza, M. Catherine (Author) , Rodríguez-Abreu, Delvys (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
4
Updated analysis from KEYNOTE-189: pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non-small-cell lung cancer by Gadgeel, Shirish (Author) , Rodríguez-Abreu, Delvys (Author) , Speranza, Giovanna (Author) , Esteban, Emilio (Author) , Felip, Enriqueta (Author) , Dómine, Manuel (Author) , Hui, Rina (Author) , Hochmair, Maximilian J. (Author) , Clingan, Philip (Author) , Powell, Steven F. (Author) , Cheng, Susanna Yee-Shan (Author) , Bischoff, Helge (Author) , Peled, Nir (Author) , Grossi, Francesco (Author) , Jennens, Ross R. (Author) , Reck, Martin (Author) , Garon, Edward B. (Author) , Novello, Silvia (Author) , Rubio-Viqueira, Belén (Author) , Boyer, Michael (Author) , Kurata, Takayasu (Author) , Gray, Jhanelle E. (Author) , Yang, Jing (Author) , Bas, Tuba (Author) , Pietanza, M. Catherine (Author) , Garassino, Marina C. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource
Search Tools:
Related Subjects
Adenocarcinoma of Lung
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Cisplatin
Double-Blind Method
Female
Follow-Up Studies
Humans
Lung Neoplasms
Male
Middle Aged
Patient Reported Outcome Measures
Pemetrexed
Prognosis
Quality of Life
Survival Rate
Young Adult
combination
drug therapy
immunotherapy